Global labeling and packaging are central to clinical supply performance, shaping regulatory compliance, serialization, and design choices that affect patient safety now.
- Clinical Supply Chains For Decentralized Trials In Sub-Saharan Africa
- What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release
- Clinical Trial Supply Failures Start Before First Patient In
- Clinical Trial Supply Impact Of ICSR Processing Delays
- Achieving Forecasting And Inventory Agility In Modern Clinical Supply Chains
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- How The Iran Conflict Threatens Global Clinical Supply Chains
- Optimizing CMO/CRO Partnerships To Improve Clinical Trial Supply Performance
ON-DEMAND WEBINARS
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
Gain a deeper understanding of current directives and metrics to equip your team with the knowledge necessary to navigate the evolving landscape of sustainability.
Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, packaging specifications, and more must be identified and addressed.
Explore best practices for comparator selection and supply optimization in clinical trials, including sourcing strategies, risk mitigation, regulatory compliance, and real-world cost-saving case studies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Doctor Patient Engagement]( "Distributing Clinical Supply In The EU For Compassionate Use Programs")
Distributing Clinical Supply In The EU For Compassionate Use ProgramsExplore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.
-
![iStock-1293772969-lab-microscope-scientist-research]( "Clinical Manufacturing: What It Is And How It Works")
Clinical Manufacturing: What It Is And How It WorksClinical manufacturing is a specialized form of pharmaceutical manufacturing focused on producing drugs for clinical research. How does it work and how is it different from commercial manufacturing?
-
![GettyImages-871431000 doctor partner]( "3 Reasons Sponsors Should Own The RTSM Vendor Relationship")
3 Reasons Sponsors Should Own The RTSM Vendor RelationshipExplore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![Refrigerated Container cold chain]( "Transportation Solutions For Cell And Gene Therapy Supply Chains")
Transportation Solutions For Cell And Gene Therapy Supply ChainsDeveloping a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
![GettyImages-1201133478 biosample]( "Biosample Tracking: A Consenting Dilemma")
Biosample Tracking: A Consenting DilemmaBiosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
![iStock-486571129-supply-chain-logistics-packaging]( "Is Your Clinical Supply Strategy Ready For EU CTR?")
Is Your Clinical Supply Strategy Ready For EU CTR?One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
![GettyImages-1429005105-scientist-ipad-software-management]( "Choosing RTSM? Evaluate The Team Running It, Not Just The Software")
Choosing RTSM? Evaluate The Team Running It, Not Just The SoftwareHigh-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
![GettyImages-1298788278 drug manufacturing]( "GxP Inventory Solution Improves Clinical IP Efficiency And Compliance")
GxP Inventory Solution Improves Clinical IP Efficiency And ComplianceLearn how this biopharmaceutical research sponsor was able to centralize and digitalize the processes involved in clinical supply production through distribution using GxP Inventory.
-
![iStock-649856194-doctor-packaging-trial]( "Logistics, Transport Challenges Require Complex Solutions")
Logistics, Transport Challenges Require Complex SolutionsThe pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
